HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Osheiza Abdulmalik Selected Research

MX1520

6/2004Anti-sickling effect of MX-1520, a prodrug of vanillin: an in vivo study using rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Osheiza Abdulmalik Research Topics

Disease

4Sickle Cell Anemia (Hemoglobin S Disease)
10/2014 - 09/2008
3Anoxia (Hypoxia)
10/2014 - 06/2004
2Hemoglobinopathies
09/2015 - 02/2003
2Anemia
01/2011 - 07/2007
1Ischemia
12/2015
1Cardiovascular Diseases (Cardiovascular Disease)
12/2015
1Hemolysis
10/2014
1Cyanosis
11/2004
1Bronchopulmonary Sequestration (Pulmonary Sequestration)
06/2004
1beta-Thalassemia (Cooley's Anemia)
02/2003

Drug/Important Bio-Agent (IBA)

3OxygenIBA
10/2014 - 02/2003
3Sickle HemoglobinIBA
10/2014 - 09/2008
2Hemoglobins (Hemoglobin)IBA
10/2014 - 11/2004
2GlobinsIBA
10/2013 - 01/2011
1ProdrugsIBA
12/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2015
1efaproxiral (RSR-13)IBA
12/2015
1vanillinIBA
11/2011
1alpha-GlobinsIBA
07/2007
1MX1520IBA
06/2004

Therapy/Procedure

1Transplants (Transplant)
09/2015
1Intraperitoneal Injections
06/2004
1Oral Administration
06/2004
1Hematopoietic Stem Cell Transplantation
02/2003
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2003